On Feb. 6, TikTok, the global short-form platform, revealed its content moderation methods aimed at creating a “safe platform environment.” The company disclosed that its content guidelines are enforced through a combination of artificial intelligence (AI) technology and human content moderation tea
Celltrion announced on Feb. 6 that Rani Therapeutics (Rani) in the United States has confirmed positive topline results in the Phase 1 clinical trial of oral ustekinumab (development name: RT-111). RT-111 is an oral formulation of Celltrion’s Stelara biosimilar, CT-P43, currently under development.I
Nine out of 10 Korean manufacturers believe that overseas carbon neutrality policies such as those in the United States and Europe affect their business operations, a survey found.According to the Korea Chamber of Commerce and Industry (KCCI), which recently surveyed 300 Korean manufacturing compani
The Organization for Economic Cooperation and Development (OECD) has raised its global economic growth forecast for this year, but lowered its economic growth forecast for South Korea. While the organization said that global trade markets such as markets of semiconductors and information technology
GS E&C’s business license has been suspended for eight months for the collapse of an underground parking lot that occurred in 2023. A lot of attention is now being paid to whether its business operations will be affected by the suspension.According to sources in the construction industry on Feb. 2,
SillaJen announced on Jan. 1 that it has applied to the U.S. Food and Drug Administration (FDA) for approval to amend the Investigational New Drug (IND) application for Phase 1 clinical trials of its BAL0891 cancer drug candidate.BAL0891 is a mitotic checkpoint inhibitor (MCI) class anticancer drug
The pharmaceutical patent disputes between domestic biosimilar companies and original pharmaceutical firms are escalating.According to industry sources on Jan. 31, Samsung Bioepis and Celltrion are embroiled in patent disputes with original pharmaceutical companies.Alexion Pharmaceuticals, a subsidi
Daewoong Pharmaceutical announced on Jan. 30 that its partner, AEON Biopharma, presented the Phase 2 clinical trial results and preclinical PTSD data of Daewoong’s botulinum toxin ABP-450 at the TOXINS 2024 conference. TOXINS 2024, a significant conference on neurotoxins, took place in Berlin, Germa
Excessive administration of analgesic drugs frequently results in medical accidents. To prevent the occurrence of these accidents, a drug infusion pump featuring a technology for safely detecting medication administration has been developed for the first time in the world.The research team led by Pr
Hugel announced on Jan. 29 that it has launched HA fillers in Thailand. The company successfully launched the products after obtaining a product license from the Thai Food and Drug Administration (TFDA) in August last year, becoming the first company to enter the Thai HA filler, botulinum toxin, and
Celltrion announced on Jan. 29 that it has completed its application to the U.S. Food and Drug Administration (FDA) for the approval of CT-P47, a biosimilar to the autoimmune disease treatment drug Actemra (ingredient name: tocilizumab). The application was based on the results of a global Phase 3 c
Artificial Intelligence (AI) stands at the forefront of the technology supremacy battle between the U.S. and China this year.On Jan. 26, U.S. Commerce Secretary Gina Raimondo stated in an interview with Reuters that regulations mandating U.S. cloud companies to report foreign customer information fo
Hyundai Mobis announced on Jan. 24 that it has developed human-centric interior lighting technology specialized for future mobility environments.The new technology realizes a system where interior lighting interacts with users by recognizing their biorhythms and preferred usage environment and showi
On Jan. 22, Hanwha Vision announced the launch of the X-Series network video recorders (NVRs) that satisfies the U.S. National Defense Authorization Act (NDAA) and offers outstanding performance including the highest level of security and safety.The X-Series NVRs are three models: a 64-channel model
Huawei held a conference on the Top 10 Trends of Data Center Facility in 2024 and released the corresponding White Paper. At the conference, Yao Quan, President of Huawei Data Center Facility Domain, defined the three characteristics of future data centers: reliable, simplified, and sustainable. Yao
On Jan. 19, Dong-A ST NeuroBo Pharmaceuticals announced the commencement of the global Phase 2 Part 2 clinical trial for its Metabolic dysfunction-associated steatohepatitis (MASH) treatment DA-1241.Last May, the company received approval from the U.S. Food and Drug Administration (FDA) for the glob
Celltrion has launched an 80-mg dosage form of its biosimilar Yuflyma (adalimumab) for the treatment of autoimmune diseases in the United States.Celltrion said on Jan. 17 that 80 mg is the same high-concentration (100 mg/ml) formulation as the 40 mg version that became available in the United States
The author is an analyst for NH Investment & Securities. He can be reached at kyeongkeun.kang@nhqv.com -- Ed.Specialized in rechargeable battery safety solutions, Inics manufactures battery cell pads and fire-resistant barriers. It has successfully secured an initial market for EV safety-related com
SK on, a leading global electric vehicle battery manufacturer, will strengthen its partnership with Solid Power, a U.S.-based leading developer of solid-state battery technology, to accelerate the development of all-solid-state batteries (ASSBs).SK on announced today it signed a research and develop